CD22 and acute lymphoblastic leukemia: Lentiviral-based overexpression of truncated CD22ΔE12 protein but not full-length CD22 in B-ALL cells resulted in a marked increase in the sizes of blast colonies in vitro, consistent with increased self-renewal and clonogenicity [13].